Breakthrough implant offers hope to young patients facing hip replacement
Disease control
Recruiting now
This early study is testing a new, absorbable hip implant designed to repair damaged cartilage in younger patients (ages 14-64). The goal is to see if this device is safe and can reduce pain and improve function, potentially delaying or avoiding the need for a total hip replaceme…
Phase: NA • Sponsor: Cytex Therapeutics, Inc. • Aim: Disease control
Last updated Mar 18, 2026 14:41 UTC